Prospects for repurposing FDA-approved medications as Omicron spike/ACE-2 protein complex disruptors

Chandrasekaran, Jaikanth and Parasuraman, Pavadai and Theivendren, Panneerselvam and Sundar, Krishnan and Ammunje, Damodar Nayak and Balaya, Rex Devasahayam Arokia and Kunjiappan, Selvaraj (2023) Prospects for repurposing FDA-approved medications as Omicron spike/ACE-2 protein complex disruptors. Journal of Research in Pharmacy, 27 (4). pp. 1605-1614.

Full text not available from this repository.

Item Type:	Article
Depositing User:	Mr IR Admin
Last Modified:	03 Mar 2026 15:15
URI:	https://ir.vistas.ac.in/id/eprint/12912

Actions (login required)

View Item